Dr. Rocklage has over three decades of healthcare management experience with strategic leadership responsibilities that led to FDA approval of three U.S. New Drug Applications (Omniscan™, Teslascan® and Cubicin®). He has served as Chairman and CEO of Cubist Pharmaceuticals, President and CEO of Nycomed Salutar and has also held R&D positions at Salutar and Catalytica.
Location
Palm Beach Gardens, Florida
Notable investments
No items found.
Check size range(s)
$0 - $100K
$100K - $500K
$500K - $1M
$1M - $3M
$3M - $10M
Rounds their fund invests in
Seed
Series A
Rounds their fund leads
Series A
Sectors their fund invests in
Biotech
Geographies their fund invests in
USA
Browse through a massive startup database
Browse Harmonic, our favorite resource for parsing through the world's startup data.
Partner
Learn more about Harmonic
No items found.
No colleagues here yet.
Funds they're a part of
5AM Ventures
About the Fund
Aims to support early-stage companies that are working to solve important healthcare needs via cutting-edge breakthroughs in medicine and science.
View Profile
Their Colleagues
Sheets Their fund(s) are in
Round-focused Sheets
Geography-focused Sheets
Sector-focused Sheets